GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envista Holdings Corp (NYSE:NVST) » Definitions » PE Ratio without NRI
中文

Envista Holdings (Envista Holdings) PE Ratio without NRI

: 21.21 (As of Today)
View and export this data going back to 2019. Start your Free Trial

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. As of today (2024-04-24), Envista Holdings's share price is $20.145. Envista Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.95. Therefore, Envista Holdings's PE Ratio without NRI for today is 21.21.

During the past 8 years, Envista Holdings's highest PE Ratio without NRI was 98.87. The lowest was 7.27. And the median was 24.61.

Envista Holdings's EPS without NRI for the three months ended in Dec. 2023 was $0.29. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $0.95.

As of today (2024-04-24), Envista Holdings's share price is $20.145. Envista Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.61. Therefore, Envista Holdings's PE Ratio for today is At Loss.

During the past years, Envista Holdings's highest PE Ratio was 259.00. The lowest was 0.00. And the median was 23.47.

Envista Holdings's EPS (Diluted) for the three months ended in Dec. 2023 was $-1.27. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.61.

Envista Holdings's EPS (Basic) for the three months ended in Dec. 2023 was $-1.27. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.55.


Envista Holdings PE Ratio without NRI Historical Data

The historical data trend for Envista Holdings's PE Ratio without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envista Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PE Ratio without NRI
Get a 7-Day Free Trial 21.96 129.73 30.45 25.13 15.73

Envista Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PE Ratio without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.13 31.45 25.25 23.63 15.73

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Envista Holdings's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Envista Holdings PE Ratio without NRI Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Envista Holdings's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Envista Holdings's PE Ratio without NRI falls into.



Envista Holdings PE Ratio without NRI Calculation

The PE Ratio without NRI, or P/E Ratio without non-recurring items, is a financial ratio used to compare a company's market price to its EPS without NRI. Regular PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than regular PE Ratio.

Envista Holdings's PE Ratio without NRI for today is calculated as

PE Ratio without NRI=Share Price/ EPS without NRI
=20.145/0.950
=21.21

Envista Holdings's Share Price of today is $20.145.
Envista Holdings's EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.95.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

There are at least three kinds of PE Ratios used by different investors. They are Trailing Twelve Month PE Ratio, Forward PE Ratio, or PE Ratio without NRI. A new PE Ratio based on inflation-adjusted normalized PE Ratio is called Shiller PE Ratio, after Yale professor Robert Shiller.

In the case of PE Ratio without NRI, the reported earnings less the non-recurring items are used.

In the calculation of PE Ratio, the earnings per share used are the earnings per share over the past 12 months.

For Forward PE Ratio, the earnings are the expected earnings for the next twelve months.

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. Since it looks at the average over the last 10 years, Shiller PE Ratio is also called PE10.


Envista Holdings  (NYSE:NVST) PE Ratio without NRI Explanation

The PE Ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. For example, if a company earns $2 a share per year, and the stock is traded at $30, the PE Ratio is 15. Therefore it takes 15 years for the company to earn back the $30 you paid for its stock, assuming the earnings stays constant over the next 15 years.

In real business, earnings never stay constant. If a company can grow its earnings, it takes fewer years for the company to earn back the price you pay for the stock. If a company's earnings decline it takes more years. As a shareholder, you want the company to earn back the price you pay as soon as possible. Therefore, lower P/E stocks are more attractive than higher P/E stocks so long as the PE Ratio is positive. Also for stocks with the same PE Ratio, the one with faster growth business is more attractive.

If a company loses money, the PE Ratio becomes meaningless.

To compare stocks with different growth rates, Peter Lynch invented a ratio called PEG Ratio. PEG Ratio is defined as the PE Ratio divided by the growth ratio. He thinks a company with a PE Ratio equal to its growth rate is fairly valued. Still he said he would rather buy a company growing 20% a year with a PE Ratio of 20, instead of a company growing 10% a year with a PE Ratio of 10.

Because the PE Ratio measures how long it takes to earn back the price you pay, the PE Ratio can be applied to the stocks across different industries. That is why it is the one of the most important and widely used indicators for the valuation of stocks.

Similar to the PE Ratio or PS Ratio or Price-to-Operating-Cash-Flow or Price-to-Free-Cash-Flow , the PE Ratio without NRI measures the valuation based on the earning power of the company. This is where it is different from the PB Ratio , which measures the valuation based on the company's balance sheet.


Be Aware

Investors need to be aware that the PE Ratio can be misleading a lot of times, especially when the underlying business is cyclical and unpredictable. As Peter Lynch pointed out, cyclical businesses have higher profit margins at the peaks of the business cycles. Their earnings are high and PE Ratio s are artificially low. It is usually a bad idea to buy a cyclical business when the PE Ratio is low. A better ratio to identify the time to buy a cyclical businesses is the PS Ratio.


Envista Holdings PE Ratio without NRI Related Terms

Thank you for viewing the detailed overview of Envista Holdings's PE Ratio without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Envista Holdings (Envista Holdings) Business Description

Traded in Other Exchanges
Address
200 S. Kraemer Boulevard, Building E, Brea, CA, USA, 92821
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments comprising Specialty Products and Technologies and Equipment and Consumables. The Company's Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Company's Equipment & Consumables segment manufactures dental equipment and supplies used in dental offices, including digital imaging systems, software and other visualization/magnification systems.
Executives
Eric Conley officer: SVP, Orthodontics 200 S. KRAEMER BLVD, BLDG E, BREA CA 92821
Mark E Nance officer: Senior Vice President, GC, Sec 1333 S SPECTRUM BLVD #100, CHANDLER AZ 85286
Stephen Keller officer: Principal Financial Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Amir Aghdaei director, officer: PRESIDENT AND CEO C/O CREDENCE SYSTEMS CORPORATION, 1421 CALIFORNIA CIRCLE, MILPITAS CA 95035
Faez C Kaabi officer: Chief Accounting Officer 200 S. KRAEMER BLVD., BUILDING E, BREA CA 92821
Howard H Yu officer: SENIOR VICE PRESIDENT, CFO 250 S. KRAEMER BLVD., BREA CA 92821
Mischa Reis officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Curt W Bludworth officer: SENIOR VICE PRESIDENT, CHRO 250 S. KRAEMER BLVD., BREA CA 92821
Barbara B. Hulit director C/O FORTIVE CORPORATION, 6920 SEAWAY BLVD, EVERETT WA 98203
Jeffrey Kappler officer: SENIOR VICE PRESIDENT C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD, BLDG. E, BREA CA 92821
Teresa Gayle Sheppard director C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Vivek Jain director ICU MEDICAL, INC., 951 CALLE AMANECER, SAN CLEMENTE CA 92673
Jean-claude Kyrillos officer: Senior Vice President C/O ENVISTA HOLDINGS CORPORATION, 200 S. KRAEMER BLVD., BLDG. E, BREA CA 92821
Kieran Gallahue director PO BOX 684369, PARK CITY UT 84068
William K Daniel director 2135 WEST MAPLE ROAD, TROY MI 48084